ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramsey, S.D.
Right arrow Articles by Sullivan, S.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramsey, S.D.
Right arrow Articles by Sullivan, S.D.
Eur Respir J 2003; 21:29S-35S
Copyright ©ERS Journals Ltd 2003


The burden of illness and economic evaluation for COPD

S.D. Ramsey1 and S.D. Sullivan2

1 Fred Hutchinson Cancer Research Center and the Dept of Pharmacy, and 2 the Dept of Medicine, University of Washington, Seattle, WA, USA

CORRESPONDENCE: S.D. Ramsey, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North (MP-900), PO Box 19024, Seattle, WA 98109, USA. Fax: 1 2066677850. E-mail: sramsey@fhcrc.org

Keywords: direct medical costs, direct nonmedical costs, economic evaluations, friction costs, human capital, productivity costs

Received: August 21, 2002
Accepted February 20, 2003

In today's cost-conscious environment, understanding the economic implications associated with disease processes and their treatments is as important as understanding their clinical impact.

Medical expenditures for treating chronic obstructive pulmonary disease (COPD) and the indirect costs of morbidity can represent a substantial economic and social burden. Very little economic information concerning COPD is available, however, particularly outside of a few very well-developed Western nations.

This article will provide an approach for conducting high-quality studies aimed at estimating the economic burden of chronic obstructive pulmonary disease and for making economic evaluations of healthcare interventions aimed at preventing and treating this disease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.